| 1 | Consumer Staples | XLP | +3.8% |
| 2 | Utilities | XLU | +1.6% |
| 3 | Real Estate | XLRE | +1.0% |
| 4 | Healthcare | XLV | -1.0% |
| 5 | Financials | XLF | -2.6% |
| 6 | Consumer Disc. | XLY | -2.7% |
| 7 | Materials | XLB | -5.8% |
| 8 | Industrials | XLI | -7.1% |
| 9 | Communication | XLC | -8.2% |
| 10 | Energy | XLE | -11.2% |
| 11 | Technology | XLK | -21.0% |
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.
| Quarter | Date | EPS est. | Actual | Surprise | YoY | Rev. est. | Actual | Surprise | YoY | Copy |
|---|---|---|---|---|---|---|---|---|---|---|
| Q3 '26 | 11/4/264:05 PM | $0.02 | $0.05GAAP | +150% | -38% | $254.4M | $275.4M | +8.2% | +27% | |
| Q2 '26 | 8/5/264:05 PM | $0.01 | $0.00GAAP | -100% | +100% | $237.0M | $263.7M | +11.3% | +45% | |
| Q1 '26 | 5/7/264:05 PM | -$0.02 | $0.00GAAP | +100% | +100%* | $209.5M | $216.2M | +3.2% | +79% | |
| Q4 '25 | 2/26/264:05 PM | $0.07 | $0.28GAAP | +300% | n/m | $280.9M | $292.9M | +4.3% | +125% | |
| Q3 '25 | 11/5/254:00 PM | -$0.11 | $0.08GAAP | +173% | +124%* | $173.7M | $216.8M | +24.8% | +113% | |
| Q2 '25 | 8/12/254:05 PM | — | -$7.97GAAP | — | — | — | $181.4M | — | — |
n/m = not meaningful: one EPS figure is from around the IPO, before preferred stock converted and the share count settled, so the two are on different share counts.
* Q1 '26: Year-ago EPS (-3.57) was before the IPO, on far fewer shares. Restated to today's share count from SEC filings: -0.450. Q3 '25: Year-ago EPS (-2.59) was before the IPO, on far fewer shares. Restated to today's share count from SEC filings: -0.327.
GAAP = diluted EPS as filed with the SEC.